About 5-ethyl-3-[(4-methyl-1,2,5-oxadiazol-3-yl)methylamino]-1-(2-oxopentan-3-yl)pyrazin-2-one
5-ethyl-3-[(4-methyl-1,2,5-oxadiazol-3-yl)methylamino]-1-(2-oxopentan-3-yl)pyrazin-2-one (PubChem CID 22969859) has the molecular formula C15H21N5O3
and a molecular weight of 319.37 g/mol. Its IUPAC name is 5-ethyl-3-[(4-methyl-1,2,5-oxadiazol-3-yl)methylamino]-1-(2-oxopentan-3-yl)pyrazin-2-one.
Molecular Properties
| Compound Name | 5-ethyl-3-[(4-methyl-1,2,5-oxadiazol-3-yl)methylamino]-1-(2-oxopentan-3-yl)pyrazin-2-one |
| PubChem CID | 22969859 |
| Molecular Formula | C15H21N5O3 |
| Molecular Weight | 319.37 g/mol |
| Exact Mass | 319.16 |
| IUPAC Name | 5-ethyl-3-[(4-methyl-1,2,5-oxadiazol-3-yl)methylamino]-1-(2-oxopentan-3-yl)pyrazin-2-one |
| SMILES | CCc1cn(C(CC)C(C)=O)c(=O)c(NCc2nonc2C)n1 |
| InChI | InChI=1S/C15H21N5O3/c1-5-11-8-20(13(6-2)10(4)21)15(22)14(17-11)16-7-12-9(3)18-23-19-12/h8,13H,5-7H2,1-4H3,(H,16,17) |
| InChIKey | DLDYTSOOHFARCR-UHFFFAOYSA-N |
| XLogP | 1.65 |
| TPSA | 102.91 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 23 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
| MW ≤ 500 | 319.37 |
| LogP ≤ 5 | 1.65 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 8 |
Analyze 5-ethyl-3-[(4-methyl-1,2,5-oxadiazol-3-yl)methylamino]-1-(2-oxopentan-3-yl)pyrazin-2-one with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of 5-ethyl-3-[(4-methyl-1,2,5-oxadiazol-3-yl)methylamino]-1-(2-oxopentan-3-yl)pyrazin-2-one?
The IUPAC name of 5-ethyl-3-[(4-methyl-1,2,5-oxadiazol-3-yl)methylamino]-1-(2-oxopentan-3-yl)pyrazin-2-one (CID 22969859) is 5-ethyl-3-[(4-methyl-1,2,5-oxadiazol-3-yl)methylamino]-1-(2-oxopentan-3-yl)pyrazin-2-one.
What is the SMILES notation for 5-ethyl-3-[(4-methyl-1,2,5-oxadiazol-3-yl)methylamino]-1-(2-oxopentan-3-yl)pyrazin-2-one?
The canonical SMILES for 5-ethyl-3-[(4-methyl-1,2,5-oxadiazol-3-yl)methylamino]-1-(2-oxopentan-3-yl)pyrazin-2-one is CCc1cn(C(CC)C(C)=O)c(=O)c(NCc2nonc2C)n1.
What is the InChIKey of 5-ethyl-3-[(4-methyl-1,2,5-oxadiazol-3-yl)methylamino]-1-(2-oxopentan-3-yl)pyrazin-2-one?
The InChIKey is DLDYTSOOHFARCR-UHFFFAOYSA-N. The full InChI is InChI=1S/C15H21N5O3/c1-5-11-8-20(13(6-2)10(4)21)15(22)14(17-11)16-7-12-9(3)18-23-19-12/h8,13H,5-7H2,1-4H3,(H,16,17).
What are the key properties of 5-ethyl-3-[(4-methyl-1,2,5-oxadiazol-3-yl)methylamino]-1-(2-oxopentan-3-yl)pyrazin-2-one?
5-ethyl-3-[(4-methyl-1,2,5-oxadiazol-3-yl)methylamino]-1-(2-oxopentan-3-yl)pyrazin-2-one has a molecular weight of 319.37 g/mol, XLogP of 1.65, 7 rotatable bonds, 1 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for 5-ethyl-3-[(4-methyl-1,2,5-oxadiazol-3-yl)methylamino]-1-(2-oxopentan-3-yl)pyrazin-2-one is sourced from PubChem (CID 22969859), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).